MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $215 | +30.3% | 107,174 | +167.7% | 0.00% | 0.0% |
| Q1 2023 | $165 | +139.1% | 40,034 | +239.3% | 0.00% | 0.0% |
| Q4 2022 | $69 | -100.0% | 11,799 | -92.5% | 0.00% | -92.9% |
| Q3 2022 | $1,064,000 | +801.7% | 157,411 | +516.6% | 0.01% | +1300.0% |
| Q2 2022 | $118,000 | -89.3% | 25,529 | -90.8% | 0.00% | -92.9% |
| Q1 2022 | $1,106,000 | +485.2% | 277,089 | +811.1% | 0.01% | +600.0% |
| Q4 2021 | $189,000 | -34.1% | 30,411 | +43.8% | 0.00% | -33.3% |
| Q2 2021 | $287,000 | -67.0% | 21,147 | -35.3% | 0.00% | -62.5% |
| Q4 2020 | $870,000 | +3.9% | 32,704 | -27.3% | 0.01% | -52.9% |
| Q3 2020 | $837,000 | +191.6% | 44,958 | -17.5% | 0.02% | -19.0% |
| Q1 2019 | $287,000 | – | 54,498 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |